John F. Neylan

Interleukin-2–Receptor Blockade with Daclizumab to Prevent Acute Rejection in Renal Transplantation

F. Vincenti, Robert L. Kirkman, Susan Light et al. · New England Journal of Medicine · 1998 · 876 citations · Full text

Medicine, Immunology, Pharmacology +17

Conversion From Calcineurin Inhibitors to Sirolimus Maintenance Therapy in Renal Allograft Recipients: 24-Month Efficacy and Safety Results From the CONVERT Trial

Francesco Paolo Schena, M.D. Pascoe, Josefina Alberú et al. · Transplantation · 2009 · 576 citations

Pharmacy, Nephrology, Pharmacotherapy +17

Sirolimus Therapy after Early Cyclosporine Withdrawal Reduces the Risk for Cancer in Adult Renal Transplantation

Josep M. Campistol, Josette Eris, Rainer Oberbauer et al. · Journal of the American Society of Nephrology · 2006 · 474 citations

Medicine, Oncology, Pharmacology +14

RESULTS OF THE DOUBLE-BLIND, RANDOMIZED, MULTICENTER, PHASE III CLINICAL TRIAL OF THYMOGLOBULIN VERSUS ATGAM IN THE TREATMENT OF ACUTE GRAFT REJECTION EPISODES AFTER RENAL TRANSPLANTATION1,2

A. Osama Gaber, M. Roy First, Raymond J. Tesi et al. · Transplantation · 1998 · 301 citations

Life Sciences, Immunology, Nephrology +17

SIROLIMUS REDUCES THE INCIDENCE OF ACUTE REJECTION EPISODES DESPITE LOWER CYCLOSPORINE DOSES IN CAUCASIAN RECIPIENTS OF MISMATCHED PRIMARY RENAL ALLOGRAFTS: A PHASE II TRIAL1

Barry D. Kahan, Bruce A. Julian, Mark D. Pescovitz et al. · Transplantation · 1999 · 280 citations

Life Sciences, Immunology, Pharmacotherapy +17